SPDR S&P Biotech ETF
196 hedge funds and large institutions have $3.25B invested in SPDR S&P Biotech ETF in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 149 increasing their positions, 9 reducing their positions, and 33 closing their positions.
Holders
196
Holders Change
+3
Holders Change %
+1.55%
% of All Funds
5.48%
Holding in Top 10
6
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-45.45%
% of All Funds
0.17%
New
38
Increased
149
Reduced
9
Closed
33
Calls
$525M
Puts
$1.34B
Net Calls
-$819M
Net Calls Change
+$557M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$925M |
| 2 |
2
Morgan Stanley
New York
|
$746M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$222M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$244M |
| 5 |
5
Citigroup
New York
|
$177M |
